Exchange: NYSE·Updated 11:12 AM EDT

BSX News

News
all
press releases
Why Boston Scientific (BSX) Outpaced the Stock Market Today
Boston Scientific (BSX) reached $42.73 at the closing of the latest trading day, reflecting a +1.64% change compared to its last close.
Zacks
Why Boston Scientific (BSX) Outpaced the Stock Market Today
Boston Scientific (BSX) reached $42.73 at the closing of the latest trading day, reflecting a +1.64% change compared to its last close.
Zacks
More News
Boston Scientific (BSX) Advances While Market Declines: Some Information for Investors
Boston Scientific (BSX) concluded the recent trading session at $42.04, signifying a +1.11% move from its prior day's close.
Zacks
Boston Scientific Corporation (BSX) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Boston Scientific (BSX). This makes it worthwhile to examine what the stock has in store.
Zacks
Boston Scientific appoints Joseph M. Fitzgerald Executive Vice President and Chief Operating Officer
Boston Scientific appoints Joseph M. Fitzgerald Executive Vice President and Chief Operating Officer Boston Scientific appoints Joseph M. Fitzgerald Executive Vice President and Chief Operating OfficerPR NewswireMARLBOROUGH, Mass., Oct. 7, 2026New operating structure designed to increase efficiency...
PR Newswire
Can J&J's MedTech Business Rebound in Q3 After Q2 Slowdown?
J&J's MedTech faces Abiomed and competitive pressures, but Vision, Orthopedics and Surgery could drive a stronger second half.
Zacks
Boston Scientific (BSX) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, Boston Scientific (BSX) closed at $42.6, marking a -1.46% move from the previous day.
Zacks
If You Invested $1000 In Boston Scientific Stock 15 Years Ago, You Would Have This Much Today
Boston Scientific (NYSE:BSX) has outperformed the market over the past 15 years by 1.13% on an annualized basis producing an average annual return of 14.35%. Currently, Boston Scientific has a market capitalization ofread more...
Benzinga
Can ISRG Offset China Weakness With Expansion in India and Japan?
Intuitive Surgical sees strong growth in India and improving conditions in Japan helping offset China headwinds as international da Vinci procedures rise 20%.
Zacks
Boston Scientific's MedSurg Diversification Bolsters Growth Prospects
BSX's MedSurg segment supports growth, with Endoscopy and Neuromodulation gains offsetting Urology challenges and portfolio gaps.
Zacks
FDA Flags Boston Scientific Catheter Recall
Boston Scientific recalls Imager II Angiographic Catheters over tip detachment defect. Learn about patient risks & FDA safety updates.read more...
Benzinga

Advertisement|Remove ads.